nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Prednisone—chronic obstructive pulmonary disease	0.497	1	CrCtD
Danazol—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0268	0.0974	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0261	0.095	CrCrCtD
Danazol—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.026	0.0945	CrCrCtD
Danazol—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0254	0.0922	CrCrCtD
Danazol—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.0233	0.0848	CrCrCtD
Danazol—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.0227	0.0826	CrCrCtD
Danazol—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.0227	0.0826	CrCrCtD
Danazol—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.0227	0.0825	CrCrCtD
Danazol—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0221	0.0805	CrCrCtD
Danazol—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0197	0.0717	CrCrCtD
Danazol—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.019	0.069	CrCrCtD
Danazol—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0185	0.0673	CrCrCtD
Danazol—CCL2—alveolus of lung—chronic obstructive pulmonary disease	0.0175	0.498	CbGeAlD
Danazol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0148	0.282	CbGbCtD
Danazol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00998	0.19	CbGbCtD
Danazol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00952	0.182	CbGbCtD
Danazol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00848	0.162	CbGbCtD
Danazol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00498	0.0949	CbGbCtD
Danazol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0047	0.0896	CbGbCtD
Danazol—CCL2—respiratory system—chronic obstructive pulmonary disease	0.00176	0.0502	CbGeAlD
Danazol—CCL2—connective tissue—chronic obstructive pulmonary disease	0.00155	0.0442	CbGeAlD
Danazol—CCL2—bronchus—chronic obstructive pulmonary disease	0.00145	0.0413	CbGeAlD
Danazol—CCL2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00142	0.0404	CbGeAlD
Danazol—CCL2—trachea—chronic obstructive pulmonary disease	0.0013	0.0371	CbGeAlD
Danazol—CCL2—lung—chronic obstructive pulmonary disease	0.000936	0.0267	CbGeAlD
Danazol—PGR—respiratory system—chronic obstructive pulmonary disease	0.000927	0.0264	CbGeAlD
Danazol—SHBG—connective tissue—chronic obstructive pulmonary disease	0.000906	0.0258	CbGeAlD
Danazol—PGR—connective tissue—chronic obstructive pulmonary disease	0.000816	0.0232	CbGeAlD
Danazol—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000746	0.0212	CbGeAlD
Danazol—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.000734	0.0209	CbGeAlD
Danazol—ESR1—respiratory system—chronic obstructive pulmonary disease	0.000725	0.0206	CbGeAlD
Danazol—AR—connective tissue—chronic obstructive pulmonary disease	0.00065	0.0185	CbGeAlD
Danazol—ESR1—connective tissue—chronic obstructive pulmonary disease	0.000638	0.0182	CbGeAlD
Danazol—AR—bronchus—chronic obstructive pulmonary disease	0.000608	0.0173	CbGeAlD
Danazol—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000595	0.0169	CbGeAlD
Danazol—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000584	0.0166	CbGeAlD
Danazol—PGR—lung—chronic obstructive pulmonary disease	0.000492	0.014	CbGeAlD
Danazol—AR—lung—chronic obstructive pulmonary disease	0.000392	0.0112	CbGeAlD
Danazol—ESR1—lung—chronic obstructive pulmonary disease	0.000385	0.011	CbGeAlD
Danazol—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.0036	CcSEcCtD
Danazol—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000298	0.00355	CcSEcCtD
Danazol—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00355	CcSEcCtD
Danazol—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.00352	CcSEcCtD
Danazol—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000293	0.0035	CcSEcCtD
Danazol—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000292	0.00348	CcSEcCtD
Danazol—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00346	CcSEcCtD
Danazol—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00029	0.00345	CcSEcCtD
Danazol—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.00344	CcSEcCtD
Danazol—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00335	CcSEcCtD
Danazol—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00324	CcSEcCtD
Danazol—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000269	0.00321	CcSEcCtD
Danazol—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.0032	CcSEcCtD
Danazol—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00317	CcSEcCtD
Danazol—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00317	CcSEcCtD
Danazol—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00315	CcSEcCtD
Danazol—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00315	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00312	CcSEcCtD
Danazol—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00309	CcSEcCtD
Danazol—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00307	CcSEcCtD
Danazol—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00306	CcSEcCtD
Danazol—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00306	CcSEcCtD
Danazol—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00301	CcSEcCtD
Danazol—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00296	CcSEcCtD
Danazol—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00295	CcSEcCtD
Danazol—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.00293	CcSEcCtD
Danazol—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000245	0.00292	CcSEcCtD
Danazol—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00291	CcSEcCtD
Danazol—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000243	0.0029	CcSEcCtD
Danazol—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00289	CcSEcCtD
Danazol—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.00286	CcSEcCtD
Danazol—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.0028	CcSEcCtD
Danazol—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000234	0.00279	CcSEcCtD
Danazol—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00278	CcSEcCtD
Danazol—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00278	CcSEcCtD
Danazol—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000231	0.00275	CcSEcCtD
Danazol—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00274	CcSEcCtD
Danazol—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00023	0.00274	CcSEcCtD
Danazol—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00272	CcSEcCtD
Danazol—Acne—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00269	CcSEcCtD
Danazol—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.00269	CcSEcCtD
Danazol—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00267	CcSEcCtD
Danazol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000224	0.00267	CcSEcCtD
Danazol—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000222	0.00265	CcSEcCtD
Danazol—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.00265	CcSEcCtD
Danazol—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000221	0.00263	CcSEcCtD
Danazol—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00257	CcSEcCtD
Danazol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000216	0.00257	CcSEcCtD
Danazol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000214	0.00255	CcSEcCtD
Danazol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000214	0.00254	CcSEcCtD
Danazol—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00254	CcSEcCtD
Danazol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000212	0.00253	CcSEcCtD
Danazol—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00253	CcSEcCtD
Danazol—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.0025	CcSEcCtD
Danazol—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000208	0.00248	CcSEcCtD
Danazol—Tension—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00246	CcSEcCtD
Danazol—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00246	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.000206	0.0768	CbGdCrCtD
Danazol—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00244	CcSEcCtD
Danazol—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00244	CcSEcCtD
Danazol—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00244	CcSEcCtD
Danazol—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00243	CcSEcCtD
Danazol—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00243	CcSEcCtD
Danazol—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00241	CcSEcCtD
Danazol—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00241	CcSEcCtD
Danazol—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00241	CcSEcCtD
Danazol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000201	0.0024	CcSEcCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.0749	CbGdCrCtD
Danazol—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00238	CcSEcCtD
Danazol—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00238	CcSEcCtD
Danazol—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000199	0.00237	CcSEcCtD
Danazol—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00236	CcSEcCtD
Danazol—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00235	CcSEcCtD
Danazol—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00235	CcSEcCtD
Danazol—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00233	CcSEcCtD
Danazol—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00231	CcSEcCtD
Danazol—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000194	0.0023	CcSEcCtD
Danazol—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.0023	CcSEcCtD
Danazol—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00229	CcSEcCtD
Danazol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00228	CcSEcCtD
Danazol—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00228	CcSEcCtD
Danazol—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00224	CcSEcCtD
Danazol—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00222	CcSEcCtD
Danazol—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00222	CcSEcCtD
Danazol—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00222	CcSEcCtD
Danazol—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00222	CcSEcCtD
Danazol—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00217	CcSEcCtD
Danazol—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00217	CcSEcCtD
Danazol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00217	CcSEcCtD
Danazol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00217	CcSEcCtD
Danazol—CCL2—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.0672	CbGdCrCtD
Danazol—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00215	CcSEcCtD
Danazol—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00214	CcSEcCtD
Danazol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.00214	CcSEcCtD
Danazol—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00214	CcSEcCtD
Danazol—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00214	CcSEcCtD
Danazol—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00213	CcSEcCtD
Danazol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00213	CcSEcCtD
Danazol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00213	CcSEcCtD
Danazol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00213	CcSEcCtD
Danazol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00213	CcSEcCtD
Danazol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00213	CcSEcCtD
Danazol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.0021	CcSEcCtD
Danazol—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00209	CcSEcCtD
Danazol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00209	CcSEcCtD
Danazol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00208	CcSEcCtD
Danazol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00205	CcSEcCtD
Danazol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00205	CcSEcCtD
Danazol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00205	CcSEcCtD
Danazol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00202	CcSEcCtD
Danazol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00202	CcSEcCtD
Danazol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00201	CcSEcCtD
Danazol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00201	CcSEcCtD
Danazol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000168	0.002	CcSEcCtD
Danazol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.002	CcSEcCtD
Danazol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00197	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.000164	0.0609	CbGdCrCtD
Danazol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00194	CcSEcCtD
Danazol—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00191	CcSEcCtD
Danazol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00191	CcSEcCtD
Danazol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.0019	CcSEcCtD
Danazol—CCL2—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.0594	CbGdCrCtD
Danazol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00189	CcSEcCtD
Danazol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00187	CcSEcCtD
Danazol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00187	CcSEcCtD
Danazol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00187	CcSEcCtD
Danazol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00183	CcSEcCtD
Danazol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.0018	CcSEcCtD
Danazol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000151	0.0018	CcSEcCtD
Danazol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000151	0.0018	CcSEcCtD
Danazol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.0018	CcSEcCtD
Danazol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.00178	CcSEcCtD
Danazol—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00178	CcSEcCtD
Danazol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00177	CcSEcCtD
Danazol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00177	CcSEcCtD
Danazol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00177	CcSEcCtD
Danazol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00176	CcSEcCtD
Danazol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00175	CcSEcCtD
Danazol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00175	CcSEcCtD
Danazol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00174	CcSEcCtD
Danazol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00173	CcSEcCtD
Danazol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00172	CcSEcCtD
Danazol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.00171	CcSEcCtD
Danazol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00171	CcSEcCtD
Danazol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.0017	CcSEcCtD
Danazol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000143	0.0017	CcSEcCtD
Danazol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.0017	CcSEcCtD
Danazol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.00169	CcSEcCtD
Danazol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00168	CcSEcCtD
Danazol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00167	CcSEcCtD
Danazol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00165	CcSEcCtD
Danazol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00163	CcSEcCtD
Danazol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00163	CcSEcCtD
Danazol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00162	CcSEcCtD
Danazol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00162	CcSEcCtD
Danazol—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00162	CcSEcCtD
Danazol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.00161	CcSEcCtD
Danazol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.0016	CcSEcCtD
Danazol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.0016	CcSEcCtD
Danazol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.0016	CcSEcCtD
Danazol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00159	CcSEcCtD
Danazol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.00159	CcSEcCtD
Danazol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00159	CcSEcCtD
Danazol—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00157	CcSEcCtD
Danazol—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00157	CcSEcCtD
Danazol—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00156	CcSEcCtD
Danazol—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00155	CcSEcCtD
Danazol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00154	CcSEcCtD
Danazol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00153	CcSEcCtD
Danazol—CCL2—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.000128	0.0476	CbGdCrCtD
Danazol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.00151	CcSEcCtD
Danazol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00151	CcSEcCtD
Danazol—CCL2—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.0464	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.0462	CbGdCrCtD
Danazol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00147	CcSEcCtD
Danazol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00147	CcSEcCtD
Danazol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00145	CcSEcCtD
Danazol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00145	CcSEcCtD
Danazol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00144	CcSEcCtD
Danazol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00142	CcSEcCtD
Danazol—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00139	CcSEcCtD
Danazol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00139	CcSEcCtD
Danazol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00137	CcSEcCtD
Danazol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00136	CcSEcCtD
Danazol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00136	CcSEcCtD
Danazol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00133	CcSEcCtD
Danazol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.0013	CcSEcCtD
Danazol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000109	0.0013	CcSEcCtD
Danazol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000109	0.00129	CcSEcCtD
Danazol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.00129	CcSEcCtD
Danazol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000108	0.00129	CcSEcCtD
Danazol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.00129	CcSEcCtD
Danazol—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00129	CcSEcCtD
Danazol—CCL2—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.000108	0.0402	CbGdCrCtD
Danazol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.00128	CcSEcCtD
Danazol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000108	0.00128	CcSEcCtD
Danazol—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00128	CcSEcCtD
Danazol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00128	CcSEcCtD
Danazol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000107	0.00128	CcSEcCtD
Danazol—CCL2—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.000107	0.0397	CbGdCrCtD
Danazol—Rash—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00127	CcSEcCtD
Danazol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00126	CcSEcCtD
Danazol—CCL2—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.000106	0.0393	CbGdCrCtD
Danazol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00126	CcSEcCtD
Danazol—CCL2—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.0393	CbGdCrCtD
Danazol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00125	CcSEcCtD
Danazol—CCL2—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.0388	CbGdCrCtD
Danazol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00124	CcSEcCtD
Danazol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00123	CcSEcCtD
Danazol—CCL2—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.0384	CbGdCrCtD
Danazol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00122	CcSEcCtD
Danazol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00122	CcSEcCtD
Danazol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00122	CcSEcCtD
Danazol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00122	CcSEcCtD
Danazol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000102	0.00122	CcSEcCtD
Danazol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.00122	CcSEcCtD
Danazol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00121	CcSEcCtD
Danazol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.0012	CcSEcCtD
Danazol—CCL2—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.0001	0.0373	CbGdCrCtD
Danazol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0001	0.00119	CcSEcCtD
Danazol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	9.89e-05	0.00118	CcSEcCtD
Danazol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.86e-05	0.00117	CcSEcCtD
Danazol—CCL2—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	9.79e-05	0.0364	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.0362	CbGdCrCtD
Danazol—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.65e-05	0.00115	CcSEcCtD
Danazol—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.00114	CcSEcCtD
Danazol—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.53e-05	0.00114	CcSEcCtD
Danazol—CCL2—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	9.5e-05	0.0354	CbGdCrCtD
Danazol—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.32e-05	0.00111	CcSEcCtD
Danazol—Shock—Prednisolone—chronic obstructive pulmonary disease	9.17e-05	0.00109	CcSEcCtD
Danazol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.1e-05	0.00108	CcSEcCtD
Danazol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.01e-05	0.00107	CcSEcCtD
Danazol—Flushing—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.00105	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	8.77e-05	0.00164	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	8.64e-05	0.00162	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	8.61e-05	0.00161	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.55e-05	0.0016	CbGpPWpGaD
Danazol—CCL2—Budesonide—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.0318	CbGdCrCtD
Danazol—GNRHR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.45e-05	0.00158	CbGpPWpGaD
Danazol—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.001	CcSEcCtD
Danazol—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.41e-05	0.00158	CbGpPWpGaD
Danazol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.000997	CcSEcCtD
Danazol—CCL2—Budesonide—Prednisolone—chronic obstructive pulmonary disease	8.33e-05	0.031	CbGdCrCtD
Danazol—GNRHR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.33e-05	0.00156	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.3e-05	0.00155	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.14e-05	0.00152	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.1e-05	0.00152	CbGpPWpGaD
Danazol—Progesterone—CYP1A1—chronic obstructive pulmonary disease	7.88e-05	0.16	CrCbGaD
Danazol—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000931	CcSEcCtD
Danazol—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	7.82e-05	0.00146	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	7.74e-05	0.00145	CbGpPWpGaD
Danazol—Prednisone—ALB—chronic obstructive pulmonary disease	7.64e-05	0.155	CrCbGaD
Danazol—Progesterone—CYP1A2—chronic obstructive pulmonary disease	7.6e-05	0.154	CrCbGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	7.56e-05	0.00142	CbGpPWpGaD
Danazol—Norethindrone—ALB—chronic obstructive pulmonary disease	7.53e-05	0.152	CrCbGaD
Danazol—GNRHR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.5e-05	0.00141	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	7.5e-05	0.0014	CbGpPWpGaD
Danazol—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000888	CcSEcCtD
Danazol—CCL2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.45e-05	0.0014	CbGpPWpGaD
Danazol—Testosterone—CYP1A1—chronic obstructive pulmonary disease	7.45e-05	0.151	CrCbGaD
Danazol—GNRHR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.44e-05	0.00139	CbGpPWpGaD
Danazol—Syncope—Prednisone—chronic obstructive pulmonary disease	7.44e-05	0.000886	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	7.43e-05	0.00139	CbGpPWpGaD
Danazol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.4e-05	0.000882	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.36e-05	0.00138	CbGpPWpGaD
Danazol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000869	CcSEcCtD
Danazol—CCL2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.2e-05	0.00135	CbGpPWpGaD
Danazol—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000856	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.17e-05	0.00134	CbGpPWpGaD
Danazol—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000853	CcSEcCtD
Danazol—Methyltestosterone—ALB—chronic obstructive pulmonary disease	7.15e-05	0.145	CrCbGaD
Danazol—CCL2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.12e-05	0.00133	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.12e-05	0.00133	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	7.08e-05	0.00133	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	7.07e-05	0.00132	CbGpPWpGaD
Danazol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.06e-05	0.000841	CcSEcCtD
Danazol—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	7.05e-05	0.00132	CbGpPWpGaD
Danazol—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.000839	CcSEcCtD
Danazol—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.02e-05	0.00131	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	6.92e-05	0.0013	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.92e-05	0.0013	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	6.91e-05	0.00129	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.86e-05	0.00128	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	6.84e-05	0.00128	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.81e-05	0.00128	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	6.81e-05	0.00128	CbGpPWpGaD
Danazol—Oedema—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000807	CcSEcCtD
Danazol—CCL2—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	6.73e-05	0.00126	CbGpPWpGaD
Danazol—Shock—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000794	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.63e-05	0.00124	CbGpPWpGaD
Danazol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000787	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.59e-05	0.00123	CbGpPWpGaD
Danazol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.00078	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.51e-05	0.00122	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	6.48e-05	0.00121	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.45e-05	0.00121	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	6.36e-05	0.00119	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.36e-05	0.00119	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.31e-05	0.00118	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000735	CcSEcCtD
Danazol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.16e-05	0.000734	CcSEcCtD
Danazol—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.11e-05	0.00114	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	6.09e-05	0.00114	CbGpPWpGaD
Danazol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000724	CcSEcCtD
Danazol—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.03e-05	0.00113	CbGpPWpGaD
Danazol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.00071	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	5.88e-05	0.0011	CbGpPWpGaD
Danazol—Rash—Prednisolone—chronic obstructive pulmonary disease	5.88e-05	0.0007	CcSEcCtD
Danazol—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	5.87e-05	0.0011	CbGpPWpGaD
Danazol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000699	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	5.86e-05	0.0011	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	5.86e-05	0.0011	CbGpPWpGaD
Danazol—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000695	CcSEcCtD
Danazol—Headache—Prednisolone—chronic obstructive pulmonary disease	5.84e-05	0.000695	CcSEcCtD
Danazol—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.83e-05	0.00109	CbGpPWpGaD
Danazol—Constipation—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.00069	CcSEcCtD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.78e-05	0.00108	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	5.7e-05	0.00107	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	5.63e-05	0.00105	CbGpPWpGaD
Danazol—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.54e-05	0.000659	CcSEcCtD
Danazol—CCL2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.46e-05	0.00102	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	5.45e-05	0.00102	CbGpPWpGaD
Danazol—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000641	CcSEcCtD
Danazol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000638	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.28e-05	0.000989	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.0194	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.0194	CbGdCrCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.21e-05	0.000977	CbGpPWpGaD
Danazol—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	5.12e-05	0.00096	CbGpPWpGaD
Danazol—CCL2—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	5.1e-05	0.019	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	5.1e-05	0.019	CbGdCrCtD
Danazol—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	5.07e-05	0.00095	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.99e-05	0.000935	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	4.94e-05	0.000926	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.92e-05	0.000921	CbGpPWpGaD
Danazol—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000579	CcSEcCtD
Danazol—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.85e-05	0.000908	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	4.85e-05	0.000908	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	4.83e-05	0.000905	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	4.81e-05	0.000901	CbGpPWpGaD
Danazol—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000571	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.71e-05	0.000882	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.67e-05	0.000875	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.66e-05	0.000872	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.62e-05	0.000866	CbGpPWpGaD
Danazol—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000533	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.43e-05	0.00083	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.4e-05	0.000824	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.4e-05	0.000824	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	4.34e-05	0.000813	CbGpPWpGaD
Danazol—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.000513	CcSEcCtD
Danazol—GNRHR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.27e-05	0.000801	CbGpPWpGaD
Danazol—Rash—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000509	CcSEcCtD
Danazol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000508	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.25e-05	0.000796	CbGpPWpGaD
Danazol—Headache—Prednisone—chronic obstructive pulmonary disease	4.24e-05	0.000505	CcSEcCtD
Danazol—GNRHR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.21e-05	0.000788	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.18e-05	0.000782	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	4.17e-05	0.000782	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.16e-05	0.000778	CbGpPWpGaD
Danazol—Testosterone—ALB—chronic obstructive pulmonary disease	4.15e-05	0.084	CrCbGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.14e-05	0.000776	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.09e-05	0.000766	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.03e-05	0.000754	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.03e-05	0.000754	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.02e-05	0.000753	CbGpPWpGaD
Danazol—Nausea—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000479	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.01e-05	0.000751	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	3.98e-05	0.000745	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.82e-05	0.000715	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	3.73e-05	0.000699	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.69e-05	0.000692	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.68e-05	0.000689	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.65e-05	0.000684	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	3.64e-05	0.000682	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.6e-05	0.000674	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.51e-05	0.000657	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.36e-05	0.000629	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.34e-05	0.000626	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	3.34e-05	0.000625	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.32e-05	0.000622	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.26e-05	0.00061	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.000605	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.22e-05	0.000603	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.18e-05	0.000595	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	3.17e-05	0.000594	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.15e-05	0.00059	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	3.09e-05	0.000579	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.08e-05	0.000578	CbGpPWpGaD
Danazol—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.06e-05	0.000574	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.06e-05	0.000573	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.99e-05	0.00056	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.95e-05	0.000553	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.95e-05	0.000552	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.94e-05	0.000551	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.92e-05	0.000547	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.9e-05	0.000543	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.86e-05	0.000536	CbGpPWpGaD
Danazol—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.85e-05	0.000535	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.85e-05	0.000533	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.81e-05	0.000526	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.79e-05	0.000523	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.76e-05	0.000517	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.75e-05	0.000516	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.74e-05	0.000512	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.62e-05	0.000491	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.56e-05	0.00048	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	2.55e-05	0.000477	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.54e-05	0.000475	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.53e-05	0.000473	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.49e-05	0.000466	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.47e-05	0.000462	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.46e-05	0.00046	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.44e-05	0.000457	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.42e-05	0.000454	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.4e-05	0.00045	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.36e-05	0.000442	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00044	CbGpPWpGaD
Danazol—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.33e-05	0.000437	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.31e-05	0.000433	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.27e-05	0.000426	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.26e-05	0.000423	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.26e-05	0.000423	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.24e-05	0.00042	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.21e-05	0.000414	CbGpPWpGaD
Danazol—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.17e-05	0.000407	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.16e-05	0.000405	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000404	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.15e-05	0.000403	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.12e-05	0.000397	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.06e-05	0.000387	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.05e-05	0.000384	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.05e-05	0.000384	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.02e-05	0.000378	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.02e-05	0.000378	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.01e-05	0.000376	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.97e-05	0.00037	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	1.96e-05	0.000367	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.000352	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.86e-05	0.000348	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.86e-05	0.000348	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.85e-05	0.000346	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.84e-05	0.000344	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000337	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.000334	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.78e-05	0.000334	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.76e-05	0.00033	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000324	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.73e-05	0.000323	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000321	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.7e-05	0.000319	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.68e-05	0.000314	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000309	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000299	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.59e-05	0.000298	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.57e-05	0.000295	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000292	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.51e-05	0.000283	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000282	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.49e-05	0.000279	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.44e-05	0.00027	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000269	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.44e-05	0.000269	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.42e-05	0.000266	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000262	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.37e-05	0.000257	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.00025	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.29e-05	0.000242	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000237	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.24e-05	0.000233	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000228	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.21e-05	0.000226	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000225	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000222	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.16e-05	0.000217	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.16e-05	0.000217	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.1e-05	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000207	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.09e-05	0.000204	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.08e-05	0.000203	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.06e-05	0.000199	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000196	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.00019	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.94e-06	0.000186	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.91e-06	0.000186	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.75e-06	0.000183	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.51e-06	0.000178	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.35e-06	0.000175	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.25e-06	0.000173	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.09e-06	0.00017	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.08e-06	0.00017	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.91e-06	0.000167	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.67e-06	0.000162	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.6e-06	0.000161	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.35e-06	0.000156	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.2e-06	0.000154	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.18e-06	0.000153	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.69e-06	0.000144	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.59e-06	0.000142	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.49e-06	0.00014	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.48e-06	0.00014	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.31e-06	0.000137	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.11e-06	0.000133	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.96e-06	0.00013	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.85e-06	0.000128	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.8e-06	0.000127	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.79e-06	0.000127	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.25e-06	0.000117	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.73e-06	0.000107	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.62e-06	0.000105	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.33e-06	9.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.09e-06	9.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.05e-06	9.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.99e-06	9.35e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.72e-06	8.84e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.56e-06	8.54e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.51e-06	8.45e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.32e-06	8.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.2e-06	7.86e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.08e-06	7.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	6.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.5e-06	6.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.45e-06	6.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.36e-06	6.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.3e-06	6.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.22e-06	6.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.05e-06	5.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.77e-06	5.19e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	4.75e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.07e-06	3.88e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.98e-06	3.72e-05	CbGpPWpGaD
